Your browser doesn't support javascript.
loading
A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer.
Sabichi, Anita L; Lee, J Jack; Grossman, H Barton; Liu, Suyu; Richmond, Ellen; Czerniak, Bogdan A; De la Cerda, Jorge; Eagle, Craig; Viner, Jaye L; Palmer, J Lynn; Lerner, Seth P.
Affiliation
  • Sabichi AL; Department of Medicine, Division of Hematology/Oncology, Baylor College of Medicine, Houston, Texas 77030, USA. sabichi@bcm.edu
Cancer Prev Res (Phila) ; 4(10): 1580-9, 2011 Oct.
Article in En | MEDLINE | ID: mdl-21881030
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Sulfonamides / Urinary Bladder Neoplasms / Cyclooxygenase 2 Inhibitors / Neoplasm Recurrence, Local Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Female / Humans / Male Language: En Journal: Cancer Prev Res (Phila) Journal subject: NEOPLASIAS Year: 2011 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Sulfonamides / Urinary Bladder Neoplasms / Cyclooxygenase 2 Inhibitors / Neoplasm Recurrence, Local Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Female / Humans / Male Language: En Journal: Cancer Prev Res (Phila) Journal subject: NEOPLASIAS Year: 2011 Document type: Article Affiliation country: United States